APOC1 and atopic eczema: The transgenic mice that specifically express human apoC1 in the liver and skin not only presented perturbed lipid metabolism manifested by increased plasma levels of cholesterol, triglyceride and fatty acids, they also developed a secondary particularly interesting phenotype, namely atopic dermatitis [178,179].